Search - tctmd.com

Displaying 161 - 180 of 597

Sort: Relevancy | Date

Presentation TVT 2022

Characterization and management of iatrogenic atrial septal defects after transseptal transcatheter mitral valve replacement with the Sapien 3 valve

Presenter: Lauren Ranard

June 09, 2022

Presentation TVT 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presenter: David Hsi

June 09, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

Presentation Miami Valves 2022

Septal Occluders: Not just for the intra-atrial septum

Presenter: John M. Lasala

February 04, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

TCT 602: Percutaneous Atrial Septal Defect Closure in an Adult With Ebstein Anomaly as a Palliative Therapy for Recurrent Stroke

Presenter: Alex Cubberley

November 05, 2021

Presentation TCT 2021

TCT 611: Look Before You Leap: Cardioplegia Mapping for Alcohol Septal Ablation

Presenter: Nicole Dexter

November 05, 2021

Presentation TCT 2021

TCT 536: Impella 5.5 as a Bridge To Repair in a Post-Infarct Ventricular Septal Defect

Presenter: Vidang Nguyen

November 04, 2021

Presentation TCT 2021

TCT 574: Simultaneous Transcatheter Aortic and Mitral Valves Replacements With Alcohol Septal Ablation

Presenter: Matthew Saybolt

November 04, 2021

Presentation TCT 2021

TCT 619: Trans-septal Pseudoaneurysm Closure After a Mechanical Bentall Procedure—A Long and Winding Road to Success

Presenter: Rafael Harari

November 04, 2021

Presentation TCT 2021

TCT 618: Percutaneous Closure of an Apical Left Ventricular Pseudoaneurysm

Presenter: Rohit Vyas

November 04, 2021

Presentation TCT 2021

TCT 617: TCT 617: Less Invasive Ventricular Enhancement Procedure (LIVE): First Case at HUMC

Presenter: Sayf Altabaqchali

November 04, 2021

Advertisement

Characterization and management of iatrogenic atrial septal defects after transseptal transcatheter mitral valve replacement with the Sapien 3 valve

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

TCTMD’s Top 10 Most Popular Stories for April 2022

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Septal Occluders: Not just for the intra-atrial septum

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

TCT 602: Percutaneous Atrial Septal Defect Closure in an Adult With Ebstein Anomaly as a Palliative Therapy for Recurrent Stroke

TCT 611: Look Before You Leap: Cardioplegia Mapping for Alcohol Septal Ablation

TCT 536: Impella 5.5 as a Bridge To Repair in a Post-Infarct Ventricular Septal Defect

TCT 574: Simultaneous Transcatheter Aortic and Mitral Valves Replacements With Alcohol Septal Ablation

TCT 619: Trans-septal Pseudoaneurysm Closure After a Mechanical Bentall Procedure—A Long and Winding Road to Success

TCT 618: Percutaneous Closure of an Apical Left Ventricular Pseudoaneurysm

TCT 617: TCT 617: Less Invasive Ventricular Enhancement Procedure (LIVE): First Case at HUMC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content